Targeting the TNF/IAP pathway synergizes with anti-CD3 immunotherapy in T-Cell Acute Lymphoblastic Leukemia. Avila Avila A, Nuantang K, Oliveira ML, Druillennec S, et al. Blood 2024 Mar 4:blood.2023022455. doi: 10.1182/blood.2023022455.

Read + Share

Amedeo Smart

Independent Medical Education

Avila Avila A, Nuantang K, Oliveira ML, Druillennec S, et al. Targeting the TNF/IAP pathway synergizes with anti-CD3 immunotherapy in T-Cell Acute Lymphoblastic Leukemia. Blood 2024 Mar 4:blood.2023022455. doi: 10.1182/blood.2023022455.
PMID: 38437728